CWIEX
Price
$80.07
Change
+$0.50 (+0.63%)
Updated
Jun 25 closing price
Net Assets
159.53B
MSEFX
Price
$11.64
Change
+$0.04 (+0.34%)
Updated
Jun 25 closing price
Net Assets
76.79M
Interact to see
Advertisement

CWIEX vs MSEFX

CWIEX vs MSEFX Comparison Chart in %
View a ticker or compare two or three
VS
CWIEX vs. MSEFX commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIEX is a Buy and MSEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIEX has more cash in the bank: 160B vs. MSEFX (76.8M). CWIEX pays higher dividends than MSEFX: CWIEX (1.13) vs MSEFX (0.27). CWIEX was incepted earlier than MSEFX: CWIEX (24 years) vs MSEFX (30 years). MSEFX (1.25) is less costly to investors than CWIEX (1.00). MSEFX is a more actively managed with annual turnover of: 81.15 vs. CWIEX (44.00). CWIEX has a lower initial minimum investment than MSEFX: CWIEX (250) vs MSEFX (10000). CWIEX annual gain was more profitable for investors over the last year : 16.34 vs. MSEFX (-1.50). CWIEX return over 5 years is better than : 31.94 vs. MSEFX (-46.06).
CWIEXMSEFXCWIEX / MSEFX
Total Expense Ratio1.000.94106%
Annual Report Gross Expense Ratio1.001.2580%
Fund Existence24 years30 years-
Gain YTD12.673-1.612-786%
Front LoadN/AN/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets160B76.8M208,333%
Annual Yield % from dividends1.130.27415%
Returns for 1 year16.34-1.50-1,091%
Returns for 3 years48.660.984,989%
Returns for 5 years31.94-46.06-69%
Returns for 10 years126.15-22.98-549%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BHCHX21.620.40
+1.89%
Baron Health Care Instl
EPLKX24.250.08
+0.33%
NYLI Epoch U.S. Equity Yield Class C
JIESX22.22N/A
N/A
JPMorgan Developed International Value I
SWTSX17.84N/A
N/A
Schwab Total Stock Market Index
MSTSX11.51N/A
N/A
Morningstar Global Opportunistic Equity